Key clinical point: The rate of osteoporosis screening and treatment among stroke patients is low.
Major finding: Only 5.1% of stroke patients undergo bone mineral density testing after their stroke.
Study details: Study of registry data from 16,581 stroke patients.
Disclosures: The study was funded by the Heart and Stroke Foundation of Canada and was supported by ICES (Institute for Clinical Evaluative Sciences) and the Ontario Ministry of Health and Long-Term Care. One author declared consultancies for the pharmaceutical sector. No other conflicts of interest were declared.
Kapoor E et al. Stroke. 2019 April 25. doi: 10.1161/STROKEAHA.118.024685.
This Week's Must Reads
Must Reads in Osteoporosis
Markers of Bone Turnover, Diabetes Examined, Diabetes Care; ePub 2018 Jul 12; Massera, et al
Bisphosphonate Drug Holidays and Fracture Risk, Endocr Pract; 2018 Feb; Bindon, Adams, et al
ACP Updates Osteoporosis Guideline, Ann Intern Med; ePub 2017 May 9; Qaseem, et al
FDA Approves Tymlos to Treat Osteoporosis, Radius news release; 2017 Apr 28